Strategies and methods for laparoscopic-assisted and robotic-assisted R 0 resection of perihilar cholangiocarcinoma
10.3760/cma.j.cn115610-20250430-00174
- VernacularTitle:腹腔镜和机器人辅助肝门部胆管癌R 0切除的策略与方法
- Author:
Jingdong LI
1
;
Yuzhu XIAO
1
Author Information
1. 川北医学院附属医院肝胆外一科 国家临床重点专科 国家消化系统疾病临床医学研究中心分中心 四川省消化系统疾病临床医学研究中心 肝病精准与微创诊疗南充市重点实验室 川北医学院肝胆胰肠疾病研究所,南充 637001
- Publication Type:Journal Article
- Keywords:
Biliary tract neoplasms;
Perihilar cholangiocarcinoma;
Robotic technology;
R 0 resection;
Margin;
Surgery;
Complication;
Laparoscopy
- From:
Chinese Journal of Digestive Surgery
2025;24(7):848-854
- CountryChina
- Language:Chinese
-
Abstract:
Perihilar cholangiocarcinoma is a malignant tumor originating from the biliary tract epithelium. Due to its unique biological behavior, radical resection remains the most effective treatment currently, with patient survival rate highly correlated with R 0 resection. However, perihilar cholangiocarcinoma tends to invade and spread to the hilar structures, often necessitating complex surgical procedures with low R 0 resection rate. In recent years, with the continuous development of laparoscopic and robotic technology, many domestic and international centers have successfully performed laparoscopic-assisted and robotic-assisted radical resection of perihilar cholangiocarcinoma, even including vascular resection and reconstruction. R 0 resection remains the essential of surgery, and some centers have begun to use the SpyGlass DS digital single-operator cholangioscopy system for preoperative intraluminal localization of tumor in the bile duct. There are also attempts to use SpyGlass system in combination with intraductal ultrasound, optical coherence tomography, confocal laser endomicroscopy and other techniques, to assist surgeons in accurately determining the resection margins, thereby achieving better R 0 resection. Based on previous literature and team experiences, the authors elaborate on the strategies and methods for laparoscopic-assisted and robotic-assisted R 0 resection of perihilar cholangiocarcinoma.